Melanoma Treatment - Chemotherapy
Chemotherapy is a medication-based, systemic therapy to treat many types of cancer, including melanoma, by destroying melanoma cells throughout the body. The success of chemotherapy in the treatment of melanoma has been shown to be limited.
Chemotherapy is prescribed and administered by a medical oncologist, a physician specially trained in oncology. The medical oncology team usually consists of physicians and specially trained nurses.
- Dacarbazine (DTIC) is the only FDA-approved chemotherapy agent for the treatment of Stage IV melanoma. It is administered as an intravenous infusion.
- Temozolomide is an oral form of dacarbazine. This medication is not FDA-approved for the treatment of melanoma, but is often used in that setting with similar efficacy to its DTIC.
- Other chemotherapy agents are sometimes used for the treatment of metastatic melanoma, including the taxanes (i.e. docetaxel, paclitaxel) and platinum agents (i.e. cisplatin, carboplatin), all with limited success.
Many other chemotherapy agents are being evaluated for their use in the treatment of Stage IV melanoma as both single agents and in combination with other chemotherapy, targeted therapy and immunotherapy agents.
Isolated limb perfusion (ILP)
Isolated limb perfusion (ILP) is a technique to deliver chemotherapy to arms or legs without causing overwhelming systemic damage. Roughly half of all melanomas occur in the extremities, and about 10 percent of patients with those lesions develop a recurrence.